Form 4 for KROS Keros Therapeutics, Inc.
Accepted 2022-04-06 00:00:00 ET · period of report 2022-04-04 · accession 0001209191-22-023494 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-06 | 2022-04-04 | KROS | Lachey Jennifer | CSO | M - OptEx | $0.3 | +7,950 | 93.7K | +9% | +$2,385 |
| D | 2022-04-06 | 2022-04-04 | KROS | Lachey Jennifer | CSO | S - Sale+OE | $60.00 | -7,950 | 85.7K | -8% | -$477.0K |
| D | 2022-04-06 | 2022-04-04 | KROS | Lachey Jennifer | CSO | M - OptEx | $0.00 | -7,950 | 76.7K | -9% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-04 | M | A | 7,950 | $0.3 | 93,650 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-04 | S | D | 7,950 | $60.00 | 85,700 | D | — | — | |
| 3 | Derivative | of Shares Employee Stock Option (right to buy) | 2022-04-04 | M | D | 7,950 | $0.00 | 76,705 | D | $0.3 · — to 2028-03-25 | 7,950 Common Stock | (F2) Immediately exercisable. |